Shenzhen Cell Valley won the "New Star Case" Award of the first tumor immunotherapy New Technology Case Exhibition
The chief scientist of our company, Professor Wang Jianxun, was invited to attend the forum and gave a keynote speech on the topic of "Establishment of Industrialization System of Cellular Drugs based on retroviral Vector". At the forum, Shenzhen Cell Valley won the "New Star Case" award for the first tumor immunotherapy New technology Case demonstration.
Professor Wang Jianxun said that cell and gene therapy, as an emerging treatment mode, has become a major trend in modern medical treatment and will maintain high growth in the next 20 years. Viral vector is a good tool for gene delivery and plays an irreplaceable role in the preparation of targeted killer cells. The most widely used in cell and gene therapy is retrovirus vector, lentivirus vector, Shenzhen cell Valley's core technology - industrial retrovirus vector technology (Pack-SS and other systems) can greatly reduce the cost of industrial preparation, improve production capacity, has been with Fosun Kate and other leading pharmaceutical companies based on retrovirus vector IND pipeline, It has also conducted cooperative research with a number of famous third-class public hospitals in China, such as Union Shenzhen Hospital of Huazhong University of Science and Technology, Shenzhen Hospital of Peking University, Cancer Hospital of Chinese Academy of Medical Sciences, Beijing Children's Hospital, Cancer Prevention Center of Sun Yat-sen University, Guangzhou Women and Children's Medical Center, and successfully treated dozens of advanced cancer patients. Shenzhen Cell Valley uses core technologies to solve the "stuck neck" dilemma of key raw materials and costs of cell therapy, continuously improves service quality and product quality, and truly brings new hope to patients!
In this forum, Shenzhen Cell Valley has attracted much attention as a CGT enterprise in the emerging biomedical field. In the future, Shenzhen Cell Valley will continue to deepen the research of underlying technologies, exert its core competitiveness, and contribute more wisdom and strength to the cause of human health.
